Immune cells and tissue microenvironment (TME/IME)

The immune cells and tissue microenvironment represent a complex, multi-cellular ecosystem comprising various immune populations (such as T cells, macrophages, and dendritic cells), stromal cells (like fibroblasts), blood vessels, and the extracellular matrix. This environment serves as the primary site for physiological processes including immune surveillance, wound healing, and inflammatory responses by facilitating intricate signaling through secreted cytokines and chemokines (Source: Nature Reviews Immunology). In disease states, particularly oncology, this microenvironment is often co-opted to create an immunosuppressive niche that promotes tumor growth, metastasis, and resistance to therapy (Source: NIH/National Cancer Institute). While not a single molecular target, the components within this environment—such as PD-1/PD-L1, CTLA-4, and various interleukins—are the primary focus of modern immunotherapy. Therapeutic strategies aim to remodel the microenvironment to restore effective immune function or inhibit pathological tissue remodeling (Source: PubMed). Consequently, understanding the spatial and functional heterogeneity of this environment is critical for the development of precision medicines and the identification of predictive biomarkers.

Other names

Tumor microenvironmentImmune microenvironmentTissue stromaCellular nicheExtracellular matrix and immune infiltrate

Therapeutic agents do not target the microenvironment as a single entity but rather modulate specific molecular components within it, such as immune checkpoint receptors, cytokines, growth factors, or stromal enzymes, to alter the collective cellular behavior and signaling landscape.